These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Heitman LH; Ijzerman AP Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294 [TBL] [Abstract][Full Text] [Related]
6. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications. Millar RP; Zhu YF; Chen C; Struthers RS Br Med Bull; 2000; 56(3):761-72. PubMed ID: 11255560 [TBL] [Abstract][Full Text] [Related]
7. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis. Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528 [TBL] [Abstract][Full Text] [Related]
8. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists. Schultze-Mosgau A; Griesinger G; Altgassen C; von Otte S; Hornung D; Diedrich K Expert Opin Investig Drugs; 2005 Sep; 14(9):1085-97. PubMed ID: 16144493 [TBL] [Abstract][Full Text] [Related]
10. Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice. Nakata D; Masaki T; Tanaka A; Yoshimatsu M; Akinaga Y; Asada M; Sasada R; Takeyama M; Miwa K; Watanabe T; Kusaka M Eur J Pharmacol; 2014 Jan; 723():167-74. PubMed ID: 24333551 [TBL] [Abstract][Full Text] [Related]
11. GnRH agonists and antagonists in cancer therapy. Chengalvala MV; Pelletier JC; Kopf GS Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):399-410. PubMed ID: 14529448 [TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone and its clinical applications. Loucopoulos A; Ferin M Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010 [TBL] [Abstract][Full Text] [Related]
13. [Gonadotropin releasing hormone (GnRH) antagonists--a new provocation in gynecology]. Vladimirov Ia Akush Ginekol (Sofiia); 2002; 41(3):36-42. PubMed ID: 12145978 [TBL] [Abstract][Full Text] [Related]
14. Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea. Berardelli R; Gianotti L; Karamouzis I; Picu A; Giordano R; D'Angelo V; Zinnà D; Lanfranco F; Ghigo E; Arvat E Gynecol Endocrinol; 2011 Oct; 27(10):753-8. PubMed ID: 21204607 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Harrison GS; Wierman ME; Nett TM; Glode LM Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448 [TBL] [Abstract][Full Text] [Related]
16. A novel mammalian receptor for the evolutionarily conserved type II GnRH. Millar R; Lowe S; Conklin D; Pawson A; Maudsley S; Troskie B; Ott T; Millar M; Lincoln G; Sellar R; Faurholm B; Scobie G; Kuestner R; Terasawa E; Katz A Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9636-41. PubMed ID: 11493674 [TBL] [Abstract][Full Text] [Related]
17. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284 [TBL] [Abstract][Full Text] [Related]
18. GnRH agonists: gonadorelin, leuprolide and nafarelin. Pace JN; Miller JL; Rose LI Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275 [TBL] [Abstract][Full Text] [Related]
19. The LHRH antagonist cetrorelix: a review. Reissmann T; Schally AV; Bouchard P; Riethmiiller H; Engel J Hum Reprod Update; 2000; 6(4):322-31. PubMed ID: 10972520 [TBL] [Abstract][Full Text] [Related]
20. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B". Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]